Platform
Features
0 followers
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Employees
Links
Scott Clarke
15 members
8 members
4 members
Neogene Therapeutics
2 followers
GRAIL
27 followers
Cytokinetics
11 followers
DARI Motion, Inc.
Emergent BioSolutions
4 followers
Samsara
79 followers
Kore.ai
22 followers
Quantum Metric
20 followers
Neo4j
19 followers
Synthekine
3 followers
Bloomreach
17 followers
Discover companies